Substance Name: Clazakizumab [USAN:INN]
RN: 1236278-28-6
UNII: 4S38Z8RA9O
Notes
- A humanized monoclonal antibody specific for interleukin-6 (IL-6).
- Targets interleukin-6.
Molecular Formula
- C6426-H9972-N1724-O2032-S42
Classification Codes
- Antiviral (COVID-19)
- Autoimmune Diseases, Rheumatoid Arthritis
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Clazakizumab [USAN:INN]
Synonyms
- ALD 518
- ALD-518
- ALD518
- BMS 945429
- BMS-945429
- Clazakizumab
- Immunoglobulin G1, anti-(human interleukin-6 (B-cell stimulatory factor 2, CTL differentiation factor, hybridoma growth factor, interferon beta-2)); humanized rabbit monoclonal BMS-945429/ALD518 (300-alanine(CH2-N(sup 67)>A(sup 67)))gamma1 heavy chain (223-217')-disulfide with humanized rabbit monoclonal BMS-945429/ALD518 kappa light chain dimer (229-229'':232-232'')-bisdisulfide, O-glycosylated
- UNII-4S38Z8RA9O
Systematic Name
- Immunoglobulin G1, anti-(human interleukin 6) (human-Oryctolagus cuniculus monoclonal BMS-945429/ALD518 heavy chain), disulfide with human-Oryctolagus cuniculus monoclonal BMS-945429/ALD518 kappa-chain, dimer
Registry Numbers
CAS Registry Number
- 1236278-28-6
FDA UNII
- 4S38Z8RA9O
System Generated Number
- 1236278286